Abstract
Forty-three patients with oropharyngeal cancer treated at our hospital were reviewed retrospectively. In total, 74% were stage IV, the 2-year overall survival rate for all patients was 77%, and 31% were HPV-positive. HPV-positive patients had a significant number of advanced cancers, and a lower probability of double cancers than HPV-negative patients. The 2-year overall survival rate was 70% in HPV-positive patients and 79% in HPV-negative patients. There was no significant difference between HPV positive and negative patients.
